Phenomex stock.

In depth view into CELL (PhenomeX) stock including the latest price, news, dividend history, earnings information and financials. PhenomeX Inc (CELL) 0.9981 0.00 (0.00%) …WebAccess detailed information about the Bruker Corporation (BRKR) Share including Price, Charts, Technical Analysis, Historical data, Bruker Reports and more.Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL). Aug. 16. CI. Berenberg Bank Adjusts PhenomeX Price Target to $8 From $9, Maintains Buy Rating. Aug. 15. MT. Earnings Flash (CELL) PHENOMEX Posts Q2 Revenue $14.1M, vs. Street Est of $17.4M. Aug. 14.EMERYVILLE, Calif., May 09, 2022 -- Berkeley Lights, Inc. , a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022. Recent Highlights ...

Dec 22, 2022 · Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

CELL Stock 12 Months Forecast. Based on 5 Wall Street analysts offering 12 month price targets for PhenomeX in the last 3 months. The average price target is $1.00 with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 0.19% change from the last price of $1.00.Item 1.01 Entry into a Material Definitive Agreement. Credit Agreement with East West Bank. On March 21, 2023, PhenomeX entered into a Second Amended and Restated Loan and Security Agreement (the "PhenomeX Credit Agreement") with East West Bank, a California banking corporation ("East West Bank "), as lender, and the other parties thereto, which amends and restates that certain Amended and ...

BKD:BERBerlin Stock Exchange · BRKR:DEUGerman Composite · BKD:STUStuttgart Stock ... Bruker Completes Acquisition of PhenomeX October 3, 2023; Bruker Introduces ...3 oct 2023 ... As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market. Also, PhenomeX ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.PhenomeX Description. PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the ...

Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16 th annual PEACe Conference. EMERYVILLE, Calif., Sept. 21, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a ...

Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), for $1.00 per Share, net to …

ZebronZB-5MS PLUS. Better Peak Shape, Low Bleed, and Aqueous Stability for specialty chemical, forensic, toxicology, and food testing applications. Leading Manufacturer of HPLC Columns, GC columns, Sample Prep Products, and …Leading Manufacturer of HPLC Columns, GC columns, Sample Prep Products, and Chromatography Accessories: PhenomenexPhenomeX Inc. (Name of Subject Company) PhenomeX Inc. (Name of Persons Filing Statement) Common Stock, $0.00005 par value per share (Title of Class of Securities) 084310101 (CUSIP Number of Class of Securities) Scott Chaplin Chief Legal Officer PhenomeX Inc. 5858 Horton Street, Suite 320 Emeryville, California, 94608 (510) 858-2855All Outstanding Shares of Common Stock . of . PHENOMEX INC. at $1.00 per share, net in cash, without interest . Pursuant to the Offer to Purchase dated August 31, 2023 . by . BIRD MERGERSUB CORPORATION . a wholly-owned subsidiary . of . BRUKER CORPORATIONIsoPlexis stockholders received 0.612 shares of PhenomeX stock for each IsoPlexis share they held. (2) Includes $ 50 million in principal repayment to retire debt of IsoPlexis, as required by change in control provisions of the debt, as well as prepayment penalties and accrued interest.

You can watch PhenomeX (CELL) and buy and sell other stocks, ETFs and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Though PhenomeX’s stock jumped 60% following the announcement, it does little to counteract the catastrophic decline in share value since Berkeley went public three years ago at $22 a share, peaking in December of 2020 at $103.Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing …WebHistorical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing …WebIn depth view into CELL (PhenomeX) stock including the latest price, news, dividend history, earnings information and financials. PhenomeX Inc (CELL) 0.9981 0.00 (0.00%) …Web377.43. -0.11%. 9.38M. View today's Phenomex Inc stock price and latest CELL news and analysis. Create real-time notifications to follow any changes in the live stock price.Web

PhenomeX will host a conference call to discuss the first quarter 2023 financial results after market close on Thursday, May 11, 2023 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.Oct 4, 2023 · https://phenomex.com. PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the ...

EMERYVILLE, Calif., Nov. 18, 2020 -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares of common... | March 27, 2023Stock price history of PhenomeX from 2020 to 2023. What is the market capitalization of a company? The market capitalization sometimes referred as Marketcap, …Web0001193125-23-226363.txt : 20230831 0001193125-23-226363.hdr.sgml : 20230831 20230831161100 ACCESSION NUMBER: 0001193125-23-226363 CONFORMED SUBMISSION TYPE: SC TO-T PUBLIC DOCUMEJun 2011 - Sep 20132 years 4 months. Sacramento, California Area. - Tutored students who needed special attention. - Graded homework and exams Drew plumbing plans and mechanical plans (HVAC ...In addition, PhenomeX Inc. has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style).Stock solutions of individual standards (1000 mg/L) were prepared by dissolving known amounts in methanol, while a mixture stock solution (1 mg/mL of each compound) was obtained by proper methanol dilution of individual standard solutions. Working standard solutions were obtained by properly diluting the mixture stock solution …

Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly-owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), in ...

PhenomeX Description. PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the ...

PhenomeX share price went down by -3.48% last month. The next quarterly earnings date for PhenomeX is scheduled on May 11, 2023. PhenomeX's next ex-dividend date is May 9, 2023.MSFT. 377.43. -0.11%. 9.38M. View today's Phenomex Inc stock price and latest CELL news and analysis. Create real-time notifications to follow any changes in the live stock price.PhenomeX optofluidic and proteomic technology to be featured in several poster and podium presentations. EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that it will participate in the 19 th annual Protein Engineering & Cell Therapy Summit (PEGS) …May 11, 2023 · PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the first quarter ended March 31, 2023. Following the completion of Berkeley Lights' acquisition ... 21 ago 2023 ... ... stock transaction valued at $57.8 million. The two research hardware companies set out to provide analyses into live biological function by ...EMERYVILLE, Calif., Nov. 18, 2020 -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares of common... | March 27, 2023Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Company profile page for PhenomeX Inc including stock price, company news, press releases, executives, board members, and contact information Since it has a market capitalisation of US$45m, PhenomeX's US$61m in cash burn equates to about 136% of its market value. That suggests the company may have some funding difficulties, and we'd be ...We would like to show you a description here but the site won’t allow us.Return on Assets (ROA) of PhenomeX 2023 is 0. In 2023, PhenomeX's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year..PhenomeX Inc. (64B.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock PhenomeX Inc. | BOERSE MUENCHEN: 64B | BOERSE MUENCHEN

--PhenomeX, Inc., a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023. Achieved total revenue of $14.1 million for the second quarter of 2023 ...21 Mar, 2023, 08:02 ET. PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI …Web| March 25, 2023Under the terms of the merger agreement entered into on December 21, 2022, IsoPlexis shareholders received, for each share of IsoPlexis stock, 0.612 shares of Berkeley Lights common stock (which will be automatically converted into shares of PhenomeX common stock). With the transaction complete, former Berkeley Lights and IsoPlexis shareholders ...Instagram:https://instagram. prdmxbest covered call stocks under dollar20humana dental insurance costwinfrey weight loss PhenomeX Inc.'s ( NASDAQ:CELL) price-to-sales (or "P/S") ratio of 1.3x might make it look like a strong buy right now compared to the Life Sciences industry in the United States, where around half ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti... forever stamp value 2022prwax stock Mar 21, 2023 · PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang ... The value each CELL share was expected to gain vs. the value that each CELL share actually gained. PhenomeX Inc ( CELL) reported Q2 2023 earnings per share (EPS) of -$0.51, missing estimates of -$0.29 by 77.11%. In the same quarter last year, PhenomeX Inc 's earnings per share (EPS) was -$0.38. PhenomeX Inc is expected to release next … tax rate for day traders Aug 18, 2023 · Haemonetics’stock has risen 13.5% in the past year. Earnings estimates for Haemoneticshave increased from $3.56 to $3.74 in 2023 and $3.96 to $4.07 in 2024 in the past 30 days. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...PhenomeX was formed earlier this year when cell analysis firm Berkeley Lights closed its acquisition of proteomics firm IsoPlexis for $57.8 million in stock. In Q1, the firm reported revenues of $18.5 million, down 8 percent year over year.